Filtered By:
Specialty: Pharmaceuticals
Condition: Bleeding
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 53 results found since Jan 2013.
Bayer ’s Xarelto® significantly lowered the combined risk of stroke, cardiovascular death and heart attack in patients with chronic coronary or peripheral artery disease by 24% (for specialized target groups only)
Importantly, rivaroxaban vascular dose, 2.5 mg twice daily, plus aspirin 100 mg once daily showed an unprecedented 42% relative risk reduction in stroke and 22% in cardiovascular death compared with aspirin 100 mg once daily alone / Bleeding rates were low, and while major bleeding was increased, notably there was no significant increase in intracranial or fatal bleeding / This combination regimen demonstrated a substantial improvement in net clinical benefit of 20%
Source: Bayer Company News - August 27, 2017 Category: Pharmaceuticals Source Type: news
27.08.17: Not intended for U.S. and UK Media - Data from COMPASS study, including 27,395 patients, presented at ESC Congress 2017:
Bayer's Xarelto® significantly lowered the combined risk of stroke, cardiovascular death and heart attack in patients with chronic coronary or peripheral artery disease by 24%Importantly, rivaroxaban vascular dose, 2.5 mg twice daily, plus aspirin 100 mg once daily showed an unprecedented 42% relative risk reduction in stroke and 22% in cardiovascular death compared with aspirin 100 mg once daily alone / Bleeding rates were low, and while major bleeding was increased, notably there was no significant increase in intracranial or fatal bleeding / This combination regimen demonstrated a substantial improvement in net clinica...
Source: Bayer IR Newsfeed: Events - August 26, 2017 Category: Pharmaceuticals Source Type: news
Xarelto Lawsuit News: Bellwether Trials, Wrongful Death Allegations
Attorneys representing plaintiffs involved in national Xarelto lawsuits consolidated as multidistrict litigation provide the latest Xarelto lawsuit news update; the Onder Law Firm provide regular news...(PRWeb September 28, 2015)Read the full story at http://www.prweb.com/releases/xarelto-lawsuit/internal-bleeding-stroke/prweb12977300.htm
Source: PRWeb: Medical Pharmaceuticals - September 28, 2015 Category: Pharmaceuticals Source Type: news
Low-Dose Aspirin Recommended at Ages 50 to 69
An influential federal panel recommended daily low-dose aspirin for men and women ages 50 to 69 to prevent heart attacks, stroke and colorectal cancer, setting off what is expected to be an intense debate given the drug’s side effects, including higher risk of bleeding.
Source: WSJ.com: Health - September 15, 2015 Category: Pharmaceuticals Tags: FREE Source Type: news
New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer’s Xarelto® in Patients with Non-Valvular Atrial Fibrillation (for specialized target groups only)
Insights from more than 45,000 real-world patients with atrial fibrillation (AF) confirm
low bleeding rates for Xarelto / Late-breaking XANTUS study expands on ROCKET AF data, demonstrating Xarelto provides highly effective stroke prevention in both high- and lower-risk patients / Two-year findings from an ongoing post-marketing safety surveillance (PMSS) study show rates and patterns of major bleeding to be consistent with ROCKET AF
Source: Bayer Company News - September 1, 2015 Category: Pharmaceuticals Source Type: news
Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited
Attorneys representing clients nationwide in Xarelto lawsuits for allegations of internal bleeding and hemorrhagic stroke announce developments in the national Xarelto lawsuit multidistrict litigation...(PRWeb June 30, 2015)Read the full story at http://www.prweb.com/releases/xarelto-lawsuit-news/bleeding-attorneys/prweb12819680.htm
Source: PRWeb: Medical Pharmaceuticals - June 30, 2015 Category: Pharmaceuticals Source Type: news
Xarelto Attorneys Provide Xarelto Lawsuit Status Update
Handling Xarelto lawsuits nationwide, the Onder Law Firm provides timely Xarelto lawsuit news regarding allegations of internal bleeding and hemorrhagic stroke underway in U.S. District Court.(PRWeb March 05, 2015)Read the full story at http://www.prweb.com/releases/xarelto-bleeding-lawsuit/xarelto-lawyers/prweb12561316.htm
Source: PRWeb: Medical Pharmaceuticals - March 5, 2015 Category: Pharmaceuticals Source Type: news
Xarelto Attorney News: JPML Consolidates National Xarelto Lawsuits
Attorneys representing clients nationwide in Xarelto lawsuits for internal bleeding and hemorrhagic stroke allegedly linked to Xarelto are currently accepting new claims; eligible persons are entitled...(PRWeb January 29, 2015)Read the full story at http://www.prweb.com/releases/bleeding-lawsuit/xarelto-attorneys/prweb12478069.htm
Source: PRWeb: Medical Pharmaceuticals - January 29, 2015 Category: Pharmaceuticals Source Type: news
Xarelto Lawsuit News: WV Woman Alleges Life-Threatening Xarelto...
Attorneys handling national Xarelto lawsuits for internal bleeding and stroke at the Onder Law Firm provide a Xarelto lawsuit news update and no-obligation case review at their Xarelto Contingency...(PRWeb January 14, 2015)Read the full story at http://www.prweb.com/releases/xarelto-attorneys/bleeding-lawsuit/prweb12442279.htm
Source: PRWeb: Medical Pharmaceuticals - January 15, 2015 Category: Pharmaceuticals Source Type: news
Women: Don't Use Aspirin For Routine Prevention Of Heart Attacks, Stroke, And Cancer
Although once widely recommended, aspirin for the prevention of a first heart attack or stroke (primary prevention) has lost favor in recent years, as the large number of bleeding complications appeared to offset the reduction in cardiovascular events. But at the same time evidence has emerged demonstrating the long-term effect of aspirin in preventing colorectal cancer, leading some to think that the risk-to-benefit equation for aspirin should be reconsidered.
Source: Forbes.com Healthcare News - December 5, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
Xarelto Lawsuit Filed in New York; Woman Alleges Life Threatening...
Lawyers providing Xarelto lawsuit news on national internal bleeding and stroke claims are offering no-cost, no-obligation Xarelto lawsuit case reviews at the Onder Law Firm’s Xarelto Contingency...(PRWeb December 03, 2014)Read the full story at http://www.prweb.com/releases/Xarelto-lawsuit/bleeding-lawyer/prweb12366502.htm
Source: PRWeb: Medical Pharmaceuticals - December 4, 2014 Category: Pharmaceuticals Source Type: news
Xarelto Lawsuit News Update: Plaintiffs Argue Back, Citing Xarelto...
Xarelto attorneys handling internal bleeding and stroke claims allegedly caused by Xarelto are offering no-cost, no-obligation Xarelto lawsuit consultations at the Onder Law Firm’s Xarelto Contingency...(PRWeb November 26, 2014)Read the full story at http://www.prweb.com/releases/xarelto-lawsuit/bleeding-stroke/prweb12354261.htm
Source: PRWeb: Medical Pharmaceuticals - November 27, 2014 Category: Pharmaceuticals Source Type: news
Xarelto Lawsuit Plaintiffs File Briefs In Support of Federal...
The Firm is representing plaintiffs in Xarelto lawsuits who allegedly experienced uncontrollable bleeding, stroke, deep vein thrombosis, and other serious complications related to its use.(PRWeb November 26, 2014)Read the full story at http://www.prweb.com/releases/xarelto-lawsuit/xarelto-bleeding/prweb12357264.htm
Source: PRWeb: Medical Pharmaceuticals - November 27, 2014 Category: Pharmaceuticals Source Type: news
Xarelto Attorney News Update: Judicial Panel on Multidistrict...
Lawyers handling Xarelto lawsuit claims for internal bleeding and hemorrhagic stroke allegedly linked to Xarelto are currently accepting new claims and offering no-obligation Xarelto lawsuit...(PRWeb November 19, 2014)Read the full story at http://www.prweb.com/releases/xarelto-bleeding/lawyers/prweb12336614.htm
Source: PRWeb: Medical Pharmaceuticals - November 20, 2014 Category: Pharmaceuticals Source Type: news
Xarelto Lawyers Announce New Website with Information on Filing...
Attorneys handling Xarelto lawsuit claims for alleged internal bleeding and hemorrhagic stroke at the Onder Law Firm launch a new Xarelto Contingency Lawsuit website; a resource to the public, the...(PRWeb November 12, 2014)Read the full story at http://www.prweb.com/releases/xarelto-lawsuit/attorney/prweb12318847.htm
Source: PRWeb: Medical Pharmaceuticals - November 12, 2014 Category: Pharmaceuticals Source Type: news
